SMA at Eurordis’ multi-stakeholder symposium in Brussel

to improve patient access to rare disease therapies

Themselves with just 20% of patients across Europe accessing today’s only therapy, Spinraza™. Although some countries benefit from full access, others, not at all. SMA Europe

Publicerat av


Until those day, was my kiss of death been stronger than those of the devil. I like to ride through hellfire with him ,when I come out victorious afterwards. I'm strong and proud rheumatoid arthritis warrior Följ mig, tack! Liz - Fotoblogg Spelblogg